Trust Co Of Vermont Trimmed Its Total S A Adr (TOT) Holding; Tetraphase Pharmaceuticals (TTPH)’s Sentiment Is 1.31

October 3, 2017 - By Hazel Jackson

Tetraphase Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The company has market cap of $373.72 million. The Firm uses its chemistry technology to create antibiotics for multidrug-resistant infections. It currently has negative earnings. The Firm is developing its lead product candidate, eravacycline, a fully synthetic tetracycline derivative, as a spectrum intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of multidrug-resistant infections, including multidrug-resistant gram-negative infections.

Trust Co Of Vermont decreased Total S A Adr (TOT) stake by 71.66% reported in 2017Q2 SEC filing. Trust Co Of Vermont sold 6,342 shares as Total S A Adr (TOT)’s stock rose 7.42%. The Trust Co Of Vermont holds 2,508 shares with $125,000 value, down from 8,850 last quarter. Total S A Adr now has $134.19 billion valuation. The stock rose 0.56% or $0.3 reaching $53.63. About 41,880 shares traded. Total SA (ADR) (NYSE:TOT) has risen 13.67% since October 3, 2016 and is uptrending. It has underperformed by 3.03% the S&P500.

About 15,862 shares traded. Tetraphase Pharmaceuticals Inc (TTPH) has risen 106.58% since October 3, 2016 and is uptrending. It has outperformed by 89.88% the S&P500.

Analysts await Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) to report earnings on November, 2. They expect $-0.56 earnings per share, up 3.45% or $0.02 from last year’s $-0.58 per share. After $-0.83 actual earnings per share reported by Tetraphase Pharmaceuticals Inc for the previous quarter, Wall Street now forecasts -32.53% EPS growth.

Opaleye Management Inc. holds 0.98% of its portfolio in Tetraphase Pharmaceuticals Inc for 330,000 shares. Ecor1 Capital Llc owns 633,400 shares or 0.8% of their US portfolio. Moreover, Rhenman & Partners Asset Management Ab has 0.31% invested in the company for 300,000 shares. The Massachusetts-based Eventide Asset Management Llc has invested 0.27% in the stock. Tekla Capital Management Llc, a Massachusetts-based fund reported 1.00 million shares.

Among 23 analysts covering Total SA (NYSE:TOT), 11 have Buy rating, 0 Sell and 12 Hold. Therefore 48% are positive. Total SA had 29 analyst reports since August 24, 2015 according to SRatingsIntel. The stock of Total SA (ADR) (NYSE:TOT) earned “Buy” rating by Cowen & Co on Thursday, July 27. Jefferies downgraded Total SA (ADR) (NYSE:TOT) on Thursday, April 28 to “Hold” rating. On Thursday, September 8 the stock rating was downgraded by Bernstein to “Mkt Perform”. On Wednesday, November 2 the stock rating was downgraded by JP Morgan to “Neutral”. The firm has “Outperform” rating given on Tuesday, February 16 by Raymond James. On Thursday, December 1 the stock rating was upgraded by Independent Research to “Buy”. As per Tuesday, December 6, the company rating was downgraded by Deutsche Bank. On Tuesday, September 26 the stock rating was downgraded by RBC Capital Markets to “Hold”. Barclays Capital downgraded it to “Equal Weight” rating and $57 target in Monday, August 21 report. The stock has “Buy” rating by Jefferies on Tuesday, January 12.